Skip to main content
. 2020 Oct 15;12(10):2993. doi: 10.3390/cancers12102993
AUC Area Under the Curve
BCR BioChemical Recurrence
CAPRA Cancer of the Prostate Risk Assessment
CF Clinical Failure
cfDNA circulating cell-free DNA
COBRAc COmbined Bisulphite Restriction Analysis
ctDNA circulating tumour DNA
ddPCR Droplet Digital PCR
Df Degrees of freedom
DMR Differentially Methylated Regions
ERRBS Enhanced Reduced Representation Bisulphite Sequencing
FFPET Formalin-Fixed Paraffin-Embedded Tissue
GS Gleason Score
HM27K Infinium HumanMethylation 27K Microarray
WGBS Whole Genome Bisulphite Sequencing
HM450K Infinium HumanMethylation 450K Microarray
HR Hazard Ratio
IQR InterQuartile Range
LR Likelihood Ratio
M Multivariate
MBDCap-Seq Methyl-CpG Binding Domain Capture sequencing
MSP Methylation-Specific PCR
PCa Prostate Cancer
PCR Polymerase Chain Reaction
PSA Prostate-Specific Antigen
qMSP quantitative Methylation-Specific PCR
RP Radical Prostatectomy
RRBS Reduced Representation Bisulphite Sequencing
TCGA The Cancer Genome Atlas
TURP TransUrethral Resection of the Prostate
U Univariate